PR NEWSWIRE

Previous Stories

Appian to appoint Ignacio Bustamante as Head of Base Metals

May 30 2023 - PR NewsWire

LONDON, May 30, 2023 /PRNewswire/ — Highlights Appointment of Ignacio Bustamante, currently CEO of Hochschild Mining PLC, strengthens operational leadership…


AlphaESS and OSW Announced Global Partnership for Expanded Product Sales Worldwide

May 30 2023 - PR NewsWire

SHANGHAI, May 30, 2023 /PRNewswire/ — AlphaESS, the world-leading energy storage solution and service provider, and OSW, Australia’s leading solar…


AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer

May 29 2023 - PR NewsWire

HIGHLIGHTS Amplia’s highly selective FAK inhibitor AMP945, when used in combination with FOLFIRINOX, enhances survival in a preclinical model of…


Game On: One of Australia’s largest toy retailers is winning big with 100% network connectivity

May 29 2023 - PR NewsWire

SYDNEY, May 29, 2023 /PRNewswire/ — Mr Toys Toyworld, the leading toy and hobby specialist retailer in Queensland, was facing…


SparkLabs Cultiv8 launches CleanTech Accelerator

May 29 2023 - PR NewsWire

The new accelerator will bring the number of companies supported by SparkLabs Cultiv8 to 50. More than $AUD half a…


LG INSTAVIEW FRIDGE TO LIFT THE ‘MOODUP’ AT VIVID SYDNEY 2023

May 26 2023 - PR NewsWire

LG to Unveil Its Unique, Color-changing Refrigerator in Australia in Partnership With the Country’s Largest Festival of Creativity, Innovation and…


Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology

May 25 2023 - PR NewsWire

June 21, 2023, at The Yale Club, New York City The Company will showcase its urologic pipeline, development of novel…


TYK2/JAK1 Inhibitor AC-201 of Accropeutics Bioscience gained Human Research Ethics Committees (HREC) permission for Phase I

May 25 2023 - PR NewsWire

SUZHOU, China, May 25, 2023 /PRNewswire/ — Accropeutics Bioscience announced that its oral small molecule TYK2/JAK1 inhibitor AC-201 has been…


Hope for knee osteoarthritis sufferers with advent of global clinical trial.

May 25 2023 - PR NewsWire

Paradigm Biopharma launches clinical trial website to support development program for knee osteoarthritis therapy. MELBOURNE, Australia, May 25, 2023 /PRNewswire/…


BLUETTI Introduces its New Expandable Mobile Power AC60 & B80 to Australian Market

May 25 2023 - PR NewsWire

SYDNEY, May 25, 2023 /PRNewswire/ — BLUETTI, the leader in the clean energy storage industry, will launch its new AC60 &…


Analyse The Market From A Different Angle